This webinar will explore key barriers and recommendations to Prison Needle Exchange Program (PNEP) access and enrollment. PNEP was implemented in 2018 by the Correctional Service Canada (CSC) to provide people in prisons with access to sterile injection equipment.
This webinar helps deepen attendees’ understanding of how to use responsible Artificial Intelligence, data science and mathematical solutions to improve public health surveillance and response to emerging and re-emerging infectious disease outbreaks.
This seminar will discuss the importance of health inequalities and how, by closely monitoring and documenting them, public health surveillance provides the foundation for informed decision-making and targeted interventions.
The Centers for Disease Control and Prevention, National Wastewater Surveillance Team Lead, will highlight the current landscape of wastewater-based surveillance in the USA, and the lessons that have been learned throughout the SARS-CoV-2 pandemic and beyond.
Wastewater has already been used to show early detection of COVID-19 in some Canadian jurisdictions prior to an increase of clinically diagnosed cases. As COVID-19 can be characterized by symptomatic and asymptomatic infection, it is important to identify the presence of undiagnosed cases to minimize the likelihood of outbreaks.
Hosted by the Public Health Agency of Canada (PHAC) – Corporate Data and Surveillance Branch (CDSB) and The National Collaborating Centre for Infectious Diseases (NCCID).
This first in a new series, this seminar provides participants with an overview of public health surveillance, including foundational concepts, current gaps, and key opportunities to strengthen public health surveillance systems and the workforce behind them. It introduces a project to establish a vision for the future of public health surveillance in Canada, including how public health stakeholders from coast to coast to coast can contribute to developing this vision.
This infographic explains how people can get Helicobacter pylori, its symptoms and treatments.
There are two anti-viral treatments used for smallpox that have been repurposed for mpox, tecovirimat and brincidofovir, of which only the former has been approved for clinical use in Canada.
As of January 20, 2023 there have been 5 SARS-CoV-2 Variants of concern (VOC) that have emerged and undergone transmission around the world. A variant becomes a concern when it exhibits features of increased infectivity and/or transmissibility.
A peer-to-peer learning program on wastewater-based surveillance for COVID-19, other pathogens and agents for public health practitioners.
This webinar presents findings from the 2022 Royal Society of Canada policy brief on wastewater surveillance for SARS-CoV-2 RNA in Canada. Discussants elaborate on the application of this scientific method in the Canadian public health landscape.